Mereo BioPharma (MREO) Intangibles (2017 - 2026)
Mereo BioPharma (MREO) reported Intangibles of $381000.0 for Q1 2026, down 31.23% year-over-year from $554000.0 in Q1 2025, and down 26.16% quarter-over-quarter from $516000.0 in Q4 2025.
Mereo BioPharma (MREO) Intangibles (2017 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 10 years of Intangibles data on file, last reported at $381000.0 in Q1 2026.
- Intangibles for Q1 2026 came in at $381000.0, down 31.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $381000.0 (down 31.23% YoY), and the FY2025 annual result was $516000.0, down 19.75% from the prior year.
- Intangibles retreated to $381000.0 in Q1 2026 per MREO's latest filing, from $516000.0 in the prior quarter.
- Over five years, Intangibles peaked at $28.3 million in Q4 2022 and troughed at $381000.0 in Q1 2026.
- A 5-year average of $3.2 million and a median of $643000.0 in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2023: Intangibles slipped 14.58% in 2022, then tumbled 96.15% in 2023.
- A 5-year view of Intangibles shows it stood at $28.3 million in 2022, then slumped by 96.15% to $1.1 million in 2023, then sank by 40.96% to $643000.0 in 2024, then dropped by 19.75% to $516000.0 in 2025, then fell by 26.16% to $381000.0 in 2026.
- Business Quant data shows MREO's Intangibles at $381000.0 in Q1 2026, $516000.0 in Q4 2025, and $643000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | 381,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 381,000.00 |
| Dec 31, 2025 | 516,000.00 |
| Sep 30, 2025 | 643,000.00 |
| Jun 30, 2025 | 470,000.00 |
| Mar 31, 2025 | 554,000.00 |
| Dec 31, 2024 | 643,000.00 |
| Sep 30, 2024 | 799,000.00 |
| Jun 30, 2024 | 866,000.00 |
| Mar 31, 2024 | 972,000.00 |
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 28.29 Mn |
| Dec 31, 2021 | 33.11 Mn |
| Dec 31, 2020 | 43.58 Mn |
| Dec 31, 2019 | 57.16 Mn |
| Dec 31, 2018 | 41.99 Mn |
| Dec 31, 2017 | 43.82 Mn |